Simultaneous intrathecal injection of muscimol and endomorphin‐1 alleviates neuropathic pain in rat model of spinal cord injury

Abstract

Introduction Due to side effects of medications used for chronic pain, combination therapy seems to be an appropriate solution for alleviation of chronic pain and reducing the side effects. The role of inhibitory GABA system is well proven in reducing neuropathic pain. Also, special attention has been focused on endogenous morphine (endomorphins) in reducing chronic pain originates from damage to the nervous system. The purpose of this study is to investigate the analgesic effect of simultaneous administration of GABA agonist and endomorphin‐1 on neuropathic pain in rat model of spinal cord injury (SCI). The role of oxidative stress, NR1 subunits of NMDA receptors, and α2 subunits of GABA receptors in the spinal cord has also been investigated. Methods Spinal cord at level of T6–T8 was compressed. Three weeks after spinal cord injury, muscimol and endomorphin‐1 were injected (intrathecally once a day for 7 days) individually or in combination. Mechanical and cold allodynia, thermal and mechanical hyperalgesia were evaluated before injection and 15 and 60 min after injection. At the end of behavioral experiments, histological and biochemical evaluations were done on prepared spinal cord samples. Results Isobologram results showed that combination therapy significantly increased the pain threshold comparing to injection of endomorphin‐1 (EM) or muscimol alone. Histological studies indicated the increased expression of α2 subunits of GABA receptors, and NR1 subunits of NMDA receptors in the spinal cord. The combination therapy also increased the glutathione (GSH) and superoxide dismutase (SOD) level and decreased the malondialdehyde (MDA) levels in the spinal cord. Conclusion Simultaneous administration of muscimol and endomorphine‐1 could be a new candidate for alleviation of pain resulting from spinal cord injury.

From acute to long-term alterations in pain processing and modulation after spinal cord injury: mechanisms related to chronification of central neuropathic pain

“…41 Furthermore, alterations in inhibitory neurotransmitters' content and receptor expression occurred at Day 1 post-SCI compared to pre-SCI level, and to control-and/or shamoperated animals. 8,21,25 These studies suggest that a reduction in inhibitory control was acquired after SCI and support the temporal pattern of events in this study. Brain imaging studies reported maladaptive metabolism, structural changes, and connectivity in pain modulation structures among people with chronic CNP, compared to controls, which correlated with pain severity.…”

A potential entanglement between the spinal cord and hippocampus: Theta rhythm correlates with neurogenesis deficiency following spinal cord injury in male rats

“…The neuropathic pain was assessed by Von Frey monofilaments (Hosseini et al., 2020). Briefly, the animals were located in a cage with a wire mesh grid, provided access to the rats’ paws from the cage's floor.…”

Mycotherapy: Potential of Fungal Bioactives for the Treatment of Mental Health Disorders and Morbidities of Chronic Pain

“…Studies by Corbett 1991, demonstrate that muscimol improved social behaviour and had anxiolytic-like effects post systemic administration to test rats, similar to diazepam [ 112 ]. Additionally, muscimol when used as a combination therapy with endomorphin-1 reduced the symptoms of neuropathic pain due to spinal cord injury when administered for 7 consecutive days [ 113 ]. Bufotenine (5-HO-DMT) is an alkaloid and a substituted tryptamine similar to serotonin and psilocin, also present in the Amanita mushroom.…”